Year archive

NAVCO Pharmaceuticals — 2025 filings

All 25 regulatory filings released by NAVCO Pharmaceuticals (NAV) in 2025, sourced directly from the official regulator.

25 Filings

2025 Period

2025 filings (25)

Filing	Released	Lang
Interim MD&A - English.pdf Management Reports	2025-08-30	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q4 2025	2025-08-30	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-08-30	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-08-30	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-05-30	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings Q1 2025	2025-05-30	English
Interim MD&A - English.pdf Interim / Quarterly Report Q1 2025	2025-05-30	English
Interim financial statements/report letter from foreign issuer.pdf Interim / Quarterly Report H1 2025	2025-05-30	English
Statement of executive compensation (form 51-102F6V) - English.pdf Remuneration Information	2025-04-01	English
Notice of the meeting and record date - English.pdf Audit Report / Information	2025-03-28	English
Notice of the meeting and record date - English.pdf Regulatory Filings	2025-03-28	English
Interim MD&A - English.pdf Management Reports	2025-03-03	English
52-109FV2 - Certification of interim filings - CEO (E).pdf Regulatory Filings	2025-03-03	English
52-109FV2 - Certification of interim filings - CFO (E).pdf Regulatory Filings	2025-03-03	English
Interim financial statements/report – English.pdf Board/Management Information	2025-03-03	English
Interim financial statements/report – English.pdf Interim / Quarterly Report Q1 2025	2025-03-03	English
52-109F1R - Certification of refiled annual filings - CEO (E).pdf Regulatory Filings	2025-02-10	English
52-109F1R - Certification of refiled annual filings - CFO (E).pdf Regulatory Filings	2025-02-10	English
Annual MD&A (amended) - English.pdf Regulatory Filings	2025-02-10	English
Audited annual financial statements (amended) - English.pdf Audit Report / Information FY 2024	2025-02-10	English
AB form 13-501F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-01-29	English
ON form 13-502F1 (class 1 and 3B reporting issuers - participation fee).PDF Regulatory Filings	2025-01-29	English
52-109FV1 - Certification of annual filings - CEO (E).pdf Regulatory Filings	2025-01-29	English
Annual MD&A - English.pdf Management Reports	2025-01-29	English
Audited annual financial statements – English.pdf Audit Report / Information FY 2024	2025-01-29	English